Board of Mesco Pharmaceuticals to consider Q2 and HY results
On 14 November 2016
Mesco Pharmaceuticals announced that a meeting of the Board of Directors of the Company will be held on 14 November 2016, inter alia, to consider and take record the Un-audited Financial Results of the Company for the quarter and Half year ended 30 September 2016.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content